Media Statement From Cooper Regarding Prosecutor’s Report on John Sheridan 3/27/15

Our hearts are with the Sheridan family at this difficult time. Although the findings about his death and the death of Joyce are unfathomable to us, we will continue to remember John as a compassionate leader of Cooper who was committed to making positive change in Camden.

Posted in Newsmakers, Press Releases0 Comments

Hereditary Breast and Ovarian Cancer Syndrome in the News

Actress Angelina Jolie recently revealed that she had surgery to remove her ovaries and fallopian tubes two years after she underwent a double mastectomy to cut her cancer risk. According to Jolie, she carries a mutation of the BRCA1 gene, which sharply increases her risk of developing breast cancer and ovarian cancer. Her mother was diagnosed with the latter at age 49 and died seven years later.

“Hereditary breast and ovarian cancer syndrome (HBOC) is an inherited tendency to develop breast, ovarian and other cancers, and at a younger age than usual,” explained Generosa Grana, MD, FACP, Director of MD Anderson Cancer Center at Cooper. “The majority of HBOC is due to a mutation in either the BRCA1 or BRCA2 genes.”

These are not the only genes associated with hereditary cancer risk and a comprehensive assessment is pivotal.

Women with an inherited gene mutation have a 40 percent to 87 percent chance of developing breast cancer, compared to 12 percent of women in the general population. Women with a BRCA gene mutation also have a 10 percent to 44 percent chance of developing ovarian cancer. Men with a BRCA gene mutation are at a higher risk of developing breast and prostate cancer.

“Not everyone with the BRCA gene mutation should feel they must automatically leap to surgery,” said Dr. Grana. “The decision to proceed with surgery and the appropriate time for such will be a very individual one as it was for Ms. Jolie. However, men and women with a genetic BRCA mutation, as well as their family members, have a unique set of medical information and should consult with a physician to determine the appropriate medical care. There is an opportunity to follow specialized cancer prevention and early detection guidelines. Management plans include specific cancer screening exams, and/or preventive surgery and are tailored to each patient and their family by a team of specialists.”

A detailed family history and genetic testing are methods used to screen for the possibility of HBOC.

Further tests may be needed if the medical and family history review suggests the possibility of HBOC.

To schedule an appointment with one of the cancer specialists at MD Anderson Cancer Center at Cooper, call 1.855.MDA.COOPER (1.855.632.2667).

Posted in Newsmakers, Press Releases0 Comments

Cooper Researcher Receives NIH Grant to Study Impact of Carbon Dioxide Levels Following Cardiac Arrest

brianrobertsmdThe NIH-National Heart Lung and Blood Institute has awarded Brian W. Roberts, MD, emergency medicine physician at Cooper University Health Care and Assistant Professor of Emergency Medicine at Cooper Medical School of Rowan University (CMSRU), a Mentored Patient-Oriented Career Development grant (K23) to study post-resuscitation partial pressure of arterial carbon dioxide and neurological outcome after cardiac arrest. The grant, which will total more than $630,000, is an ancillary study built upon the previously awarded RO1 grant also awarded in 2013 from the NIH to Stephen W. Trzeciak, MD, Head of the Division of Critical Care Medicine at Cooper University Health Care and Associate Professor of Medicine and Emergency Medicine at CMSRU, to study neurological and cognitive effects of hyperoxia after cardiac arrest.

The study will be a six-center prospective observational study. The research will examine patients who have cardiac arrest, receive CPR and are successfully revived, but remain on a ventilator after CPR.

“Patients who receive CPR frequently have brain damage because of the lack of oxygen delivered to the brain while the heart was not beating on its own,” states Dr. Roberts. “We will be looking to see if there is an association between the level of carbon dioxide in the blood after CPR and the degree of brain injury after CPR.”

Previous research has shown that carbon dioxide levels in the blood have been shown to affect the amount of blood flow delivered to the brain; low carbon dioxide levels decrease blood flow and high levels increase blood flow. Physicians can control the level of carbon dioxide in the blood when a patient is on a ventilator by controlling how fast a patient breathes and thus how much carbon dioxide they breath out.

Dr. Roberts explains, “It is possible that during the initial period after the heart starts again the injured brain is at risk for additional injury from either too little or too much blood flow. We are looking for the optimal level of carbon dioxide which is associated with the least amount of brain injury. If we identify an optimal carbon dioxide range then physicians can aim for this range with the hope of decreasing brain injury after cardiac arrest and improve the patient’s outcome.”

“Cooper is internationally known for its critical care, trauma, and emergency medicine programs,” says Paul Katz, MD, Dean of CMSRU. “We are proud of Dr. Roberts for continuing this tradition of advancing medical knowledge and improving patient care for the critically ill, and we’re grateful to the NIH for recognizing the importance of this research.”

Dr. Roberts’ primary mentor on the grant is Dr. Trzeciak; intramural co-mentors include R. Phillip Dellinger, MD, Chief of the Department of Medicine at Cooper University Health Care and Chair of the Department of Medicine at CMSRU, and Steven M. Hollenberg, MD, Director of the Coronary Care Unit at Cooper and Professor of Medicine at CMSRU.

A NIH Career Development Grant allows the researcher to work toward obtaining the skills required to become an independent investigator and apply an independent research grant (R01) at the end of the five years.  The mentor team helps to guide the investigator through this multi-center project. Dr. Roberts will be working toward a master of science in clinical research and translational medicine at Temple University.

Posted in Announcements, Newsmakers, Press Releases0 Comments

Dr. Joseph Lombardi Co-Chairs International Aortic Summit

lombardi_confJoseph V. Lombardi, MD, Head of the Division of Vascular and Endovascular Surgery at Cooper University Health Care, was congress co-chairman of this year’s International Aortic Summit (IAS), held February 11-13, 2015, in Aruba.

The Summit assembled top leaders in the fields of vascular and endovascular surgery to present and discuss the latest advances in aortic surgery (both open and endovascular techniques). “Aside from a tremendous venue for our faculty and their families, there was an tremendous amount of sophisticated discussion on all forms of aortic surgery by the leaders in our field,” Dr. Lombardi said.

The IAS also featured 15 scholarships for vascular fellows who presented their work along with the faculty. “The educational experience for the fellows, as they presented their work in tandem with invited faculty, cannot be overstated,” said Dr. Lombardi. “Our mission of education and improving care for all patients with aortic pathology underscores the true essence of the IAS.” The IAS 2015 is a comprehensive educational experience open to all surgeons, cardiologists, radiologists, fellows, residents, medical students, nurse practitioners and physician assistants designed to present the latest advances in aor
tic surgery.

Posted in Announcements, Press Releases0 Comments

Latest Issue of Vascular Vitality Now Available

vascvit111Vascular Vitality magazine is an educational resource produced by the Cooper Vascular Surgery team to provide you with tools that will guide you and educate you about the various vascular conditions. Check out our latest issue of Vascular Vitality.

Posted in Press Releases0 Comments